Paladin Wealth, LLC Pfizer Inc Transaction History

Paladin Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 08, 2025	SELL	$21.59 - $24.84 $328,686 - $378,164	-15,224 Reduced 56.2%	11,864 $288 Million
Q1 2025 Apr 09, 2025	BUY	$25.01 - $27.13 $25,935 - $28,133	1,037 Added 3.98%	27,088 $686 Million
Q4 2024 Jan 29, 2025	BUY	$24.8 - $30.19 $126,380 - $153,848	5,096 Added 24.32%	26,051 $691 Million
Q3 2024 Oct 11, 2024	BUY	$27.7 - $31.39 $580,453 - $657,777	20,955 New	20,955 $606 Million

3,367

3.57B

86.1M

105M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Paladin Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Paladin Wealth, LLC with notifications on news.